If you require further searching capabilities for announcements please email: data@nzx.com

2023 Annual Shareholders’ Meeting Results

29/08/2023, 16:31 NZST, MEETING

News Release STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH) 2023 Annual Shareholders' Meeting Results Auckland, New Zealand, 29 August 2023 - Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company's annual shareholders' meeting held today were passed. The five resolutions were: Resolution 1: To re-elect Pip Greenwood as a Director. Resolution 2: To authorise the Directors to fix the fees and expenses of the company's auditor. Resolution 3: To approve an increase in the maximum aggregate annual remuneration payable to non-executive Directors Resolution 4: To approve the issue of performance share rights to Lewis Gradon as set out in the Notice of Annual Shareholders' Meeting 2023. Resolution 5: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders' Meeting 2023. All resolutions were decided by poll. The details of the total number of votes cast online, in person, via phone or by proxy on the polls were as follows: Resolution Votes: Resolution 1: Re-election of Pip Greenwood For: 427,893,291 (98.20%); Against: 7,834,272 (1.80%); Abstain: 35,346 Resolution 2: Authorise Directors to fix fees and expenses of auditor For: 425,527,974 (97.66%); Against: 10,194,972 (2.34%); Abstain: 39,963 Resolution 3: Directors' remuneration For: 360,396,312 (82.93%); Against: 74,183,490 (17.07%); Abstain: 97,679 Resolution 4: Issue of performance share rights to Lewis Gradon For: 425,084,178 (97.62%); Against: 10,377,692 (2.38%); Abstain: 299,289 Resolution 5: Issue of options to Lewis Gradon For: 421,626,407 (96.83%); Against: 13,812,449 (3.17%); Abstain: 322,303 About Fisher & Paykel Healthcare Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company's products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com. Media & Investor Contacts: Hayden Brown Head of Capital Markets and Investor Relations hayden.brown@fphcare.co.nz +64 (0) 27 807 8073 Daniel Adolph Senior Communications and Investor Relations Manager daniel.adolph@fphcare.co.nz +64 (0) 22 511 4050 Authorised by Raelene Leonard, General Counsel & Company Secretary. End CA:00417314 For:FPH Type:MEETING Time:2023-08-29 16:31:31